StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.99+0.03 (+0.76%)

Close on Nov 18, 2026Market cap $320.02MP/E –Yield –

Atea Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Atea Pharmaceuticals's price to sales ratio was 1.4× on Apr 29, 2022.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20221.4×–

More Atea Pharmaceuticals figures

See a number that looks wrong?